SABCS 2021 Update on QoL Results From OlympiA Trial: Adjuvant Olaparib After (Neo)Adjuvant Chemo in Patients With Germline BRCA1/2 Mutations and High-Risk HER2- EBC

294 views
December 23, 2021
Comments 0
Login to view comments. Click here to Login